Span Divergent Ltd

NSE: SPANDIAQ · BSE: 524727 · Pharmaceuticals & Biotechnology · 26 announcements

Share price: ₹27.10
Market cap: ₹19.68 Cr
Revenue (annual): ₹17.22 Cr
Net profit (annual): ₹-2.50 Cr
P/E (TTM): -5.4×Sector 43.8×
Promoter holding: 48.13%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 3 Other Announcement 2 Merger & Restructuring 1 Financial Results 1 Debt & Borrowing 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

5 Nov 2026 19:42 IST BSE

Merger & Restructuring

Span Divergent Merger & Restructuring Worth ₹5 Cr

Span Divergent's board approved selling its Mumbai immovable property to Glorious Sales LLP, an unrelated buyer, for up to Rs.5 Crore. Completion is expected by March 31, 2027.

Value: ₹5.00 Cr
Execution: Agreement to be executed on or before March 31, 2027; sale expected to complete on or before March 31, 2027

Open announcement → Read the filing ↗